ExamWorks Group (NYSE: EXAM ) reported earnings on Nov. 5. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Sep. 30 (Q3), ExamWorks Group beat expectations on revenues and exceeded expectations on earnings per share.
Compared to the prior-year quarter, revenue expanded significantly and GAAP loss per share grew.
Gross margins dropped, operating margins grew, net margins shrank.
ExamWorks Group booked revenue of $130.1 million. The four analysts polled by S&P Capital IQ predicted revenue of $127.1 million on the same basis. GAAP reported sales were 19% higher than the prior-year quarter's $109.2 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.14. The three earnings estimates compiled by S&P Capital IQ forecast -$0.18 per share. GAAP EPS were -$0.14 for Q3 compared to -$0.08 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 33.8%, 10 basis points worse than the prior-year quarter. Operating margin was 1.0%, 120 basis points better than the prior-year quarter. Net margin was -3.6%, 110 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $136.8 million. On the bottom line, the average EPS estimate is -$0.14.
Next year's average estimate for revenue is $515.5 million. The average EPS estimate is -$0.49.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 13 members out of 25 rating the stock outperform, and 12 members rating it underperform. Among 11 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), four give ExamWorks Group a green thumbs-up, and seven give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on ExamWorks Group is outperform, with an average price target of $15.13.
- Add ExamWorks Group to My Watchlist.